Understanding CAR-M Technology with Carisma Therapeutics' Dr. Debora Barton

<p>Carisma Therapeutics’ Dr. Barton breaks down the latest in CAR-M technology as well as the company&apos;s Phase 1 First-in-Human Study of Adenovirally Transduced Anti-HER2 CAR Macrophages in Subjects with HER2 Overexpressing Solid Tumors.</p>